Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
29.68
+0.34 (1.16%)
Nov 19, 2024, 4:00 PM EST - Market closed
Dyne Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$52.44
Upside
+76.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +68.46% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +85.31% | Nov 13, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $43 → $35 | Buy → Hold | Downgrades | $43 → $35 | +17.92% | Oct 24, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $53 | Buy | Reiterates | $53 | +78.57% | Sep 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +85.31% | Sep 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $55 | Buy | Reiterates | $55 | +85.31% | Sep 3, 2024 |
| Stifel | Stifel | Strong Buy Maintains $41 → $66 | Strong Buy | Maintains | $41 → $66 | +122.37% | Aug 16, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +68.46% | Aug 15, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $52 | Buy | Maintains | $48 → $52 | +75.20% | Aug 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $43 → $53 | Buy | Maintains | $43 → $53 | +78.57% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $55 | Strong Buy | Maintains | $48 → $55 | +85.31% | Aug 13, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $43 | Buy | Maintains | $39 → $43 | +44.88% | Jul 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $31 → $42 | Strong Buy | Maintains | $31 → $42 | +41.51% | May 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $46 → $48 | Strong Buy | Maintains | $46 → $48 | +61.73% | May 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +4.45% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $47 | Buy | Reiterates | $47 | +58.36% | May 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.